Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Smith, L.M.
Lloyd, M.L.
Harvey, N.L.
Redwood, A.J.
Lawson, M.A.
and
Shellam, G.R.
2005.
Species-specificity of a murine immunocontraceptive utilising murine cytomegalovirus as a gene delivery vector.
Vaccine,
Vol. 23,
Issue. 23,
p.
2959.
Gorman, Shelley
Harvey, Nicole L.
Moro, Dorian
Lloyd, Megan L.
Voigt, Valentina
Smith, Lee M.
Lawson, Malcolm A.
and
Shellam, Geoffrey R.
2006.
Mixed infection with multiple strains of murine cytomegalovirus occurs following simultaneous or sequential infection of immunocompetent mice.
Journal of General Virology
,
Vol. 87,
Issue. 5,
p.
1123.
Hardy, C.M.
Hinds, L.A.
Kerr, P.J.
Lloyd, M.L.
Redwood, A.J.
Shellam, G.R.
and
Strive, T.
2006.
Biological control of vertebrate pests using virally vectored immunocontraception.
Journal of Reproductive Immunology,
Vol. 71,
Issue. 2,
p.
102.
McLeod, S. R.
Saunders, G.
Twigg, L. E.
Arthur, A. D.
Ramsey, D.
and
Hinds, L. A.
2007.
Prospects for the future: is there a role for virally vectored immunocontraception in vertebrate pest management?.
Wildlife Research,
Vol. 34,
Issue. 7,
p.
555.
Redwood, Alec J.
Smith, Lee M.
Lloyd, Megan L.
Hinds, Lyn A.
Hardy, Christopher M.
and
Shellam, Geoffrey R.
2007.
Prospects for virally vectored immunocontraception in the control of wild house mice (Mus domesticus).
Wildlife Research,
Vol. 34,
Issue. 7,
p.
530.
Doom, Carmen M.
and
Hill, Ann B.
2008.
MHC class I immune evasion in MCMV infection.
Medical Microbiology and Immunology,
Vol. 197,
Issue. 2,
p.
191.
Gorman, Shelley
Lloyd, Megan L.
Smith, Lee M.
McWhorter, Andrea R.
Lawson, Malcolm A.
Redwood, Alec J.
and
Shellam, Geoffrey R.
2008.
Prior infection with murine cytomegalovirus (MCMV) limits the immunocontraceptive effects of an MCMV vector expressing the mouse zona-pellucida-3 protein.
Vaccine,
Vol. 26,
Issue. 31,
p.
3860.
Burkhardt, Christiane
Himmelein, Susanne
Britt, William
Winkler, Thomas
and
Mach, Michael
2009.
Glycoprotein N subtypes of human cytomegalovirus induce a strain-specific antibody response during natural infection.
Journal of General Virology
,
Vol. 90,
Issue. 8,
p.
1951.
Arthur, A. D.
Krebs, C. J.
Pech, R. P.
Farroway, L. N.
and
Singleton, G. R.
2009.
The transmission rate of MCMV in house mice in pens: implications for virally vectored immunocontraception.
Wildlife Research,
Vol. 36,
Issue. 5,
p.
386.
Tsuda, Yoshimi
Caposio, Patrizia
Parkins, Christopher J.
Botto, Sara
Messaoudi, Ilhem
Cicin-Sain, Luka
Feldmann, Heinz
Jarvis, Michael A.
and
Geisbert, Thomas William
2011.
A Replicating Cytomegalovirus-Based Vaccine Encoding a Single Ebola Virus Nucleoprotein CTL Epitope Confers Protection against Ebola Virus.
PLoS Neglected Tropical Diseases,
Vol. 5,
Issue. 8,
p.
e1275.
Boppana, Suresh B.
and
Britt, William J.
2014.
Human Cytomegaloviruses.
Vol. 1119,
Issue. ,
p.
311.
Dogra, Pranay
and
Sparer, Tim E.
2014.
Human Cytomegaloviruses.
Vol. 1119,
Issue. ,
p.
267.
Tsuda, Yoshimi
Parkins, Christopher J.
Caposio, Patrizia
Feldmann, Friederike
Botto, Sara
Ball, Susan
Messaoudi, Ilhem
Cicin-Sain, Luka
Feldmann, Heinz
and
Jarvis, Michael A.
2015.
A cytomegalovirus-based vaccine provides long-lasting protection against lethal Ebola virus challenge after a single dose.
Vaccine,
Vol. 33,
Issue. 19,
p.
2261.
Murphy, Aisling A.
Redwood, Alec J.
and
Jarvis, Michael A.
2016.
Self-disseminating vaccines for emerging infectious diseases.
Expert Review of Vaccines,
Vol. 15,
Issue. 1,
p.
31.
Marzi, Andrea
Murphy, Aisling A.
Feldmann, Friederike
Parkins, Christopher J.
Haddock, Elaine
Hanley, Patrick W.
Emery, Matthew J.
Engelmann, Flora
Messaoudi, Ilhem
Feldmann, Heinz
and
Jarvis, Michael A.
2016.
Cytomegalovirus-based vaccine expressing Ebola virus glycoprotein protects nonhuman primates from Ebola virus infection.
Scientific Reports,
Vol. 6,
Issue. 1,
Basinski, Andrew J.
Varrelman, Tanner J.
Smithson, Mark W.
May, Ryan H.
Remien, Christopher H.
and
Nuismer, Scott L.
2018.
Evaluating the promise of recombinant transmissible vaccines.
Vaccine,
Vol. 36,
Issue. 5,
p.
675.
Smithson, Mark W.
Basinki, Andrew J.
Nuismer, Scott L.
and
Bull, James J.
2019.
Transmissible vaccines whose dissemination rates vary through time, with applications to wildlife.
Vaccine,
Vol. 37,
Issue. 9,
p.
1153.
Boppana, Suresh B.
and
Britt, William J.
2021.
Human Cytomegaloviruses.
Vol. 2244,
Issue. ,
p.
403.
Varrelman, Tanner J.
Remien, Christopher H.
Basinski, Andrew J.
Gorman, Shelley
Redwood, Alec
and
Nuismer, Scott L.
2022.
Quantifying the effectiveness of betaherpesvirus-vectored transmissible vaccines.
Proceedings of the National Academy of Sciences,
Vol. 119,
Issue. 4,
Bruce, Kimberley
Ma, Jiawei
Lawler, Clara
Xie, Wanxiaojie
Stevenson, Philip
and
Farrell, Helen
2022.
Recent Advancements in Understanding Primary Cytomegalovirus Infection in a Mouse Model.
Viruses,
Vol. 14,
Issue. 9,
p.
1934.